Skip to main content
Top
Published in: International Journal of Public Health 5/2014

01-10-2014 | Original Article

Direct and indirect costs associated to type 2 diabetes and its complications measured in a social security institution of Argentina

Authors: Jorge F. Elgart, Santiago Asteazarán, Jorge L. De La Fuente, Cecilia Camillucci, Jonathan B. Brown, Juan José Gagliardino

Published in: International Journal of Public Health | Issue 5/2014

Login to get access

Abstract

Objectives

To estimate direct and indirect costs of care of type 2 diabetes (T2DM) and its complications in Argentina, and compare them with those recorded in people without diabetes (ND).

Methods

Observational retrospective case–control study performed in one institution of the Social Security System of Argentina. Participants were identified and randomly selected from the Institution’s electronic medical records. We recruited persons with T2DM with (387) or without (387) chronic complications and 774 ND, matched by age and gender. Data were obtained by telephone interviews and supplemented with data from the Institution’s records. Parametric and non-parametric tests were used for group comparisons.

Results

Direct costs were higher in people with T2DM than in ND: twice as high in people with T2DM without complications and 3.6 times in those with complications. Absenteeism was only higher in T2DM with complications, but there were no differences among groups either in the duration or in the cost of such absenteeism.

Conclusions

T2DM and the development of its complications are positively associated with higher direct costs in Argentina.
Literature
go back to reference Alexander GC, Sehgal NL, Moloney RM, Stafford RS (2008) National trends in treatment of type 2 diabetes mellitus, 1994–2007. Arch Intern Med 168(19):2088–2094PubMedCrossRefPubMedCentral Alexander GC, Sehgal NL, Moloney RM, Stafford RS (2008) National trends in treatment of type 2 diabetes mellitus, 1994–2007. Arch Intern Med 168(19):2088–2094PubMedCrossRefPubMedCentral
go back to reference Bertoldi AD, Kanavos P, França GV et al (2013) Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Global Health 9:62. doi:10.1186/1744-8603-9-62 PubMedCrossRef Bertoldi AD, Kanavos P, França GV et al (2013) Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Global Health 9:62. doi:10.​1186/​1744-8603-9-62 PubMedCrossRef
go back to reference Elgart JF, Caporale JE, Asteazaran S et al (2014) Association between socioeconomic status, type 2 diabetes and its chronic complications in Argentina. Diabetes Res Clin Pract 104(2):241–247PubMedCrossRef Elgart JF, Caporale JE, Asteazaran S et al (2014) Association between socioeconomic status, type 2 diabetes and its chronic complications in Argentina. Diabetes Res Clin Pract 104(2):241–247PubMedCrossRef
go back to reference Ferrante D, Linetzky B, Konfino J et al (2011) Encuesta Nacional de Factores de Riesgo 2009: evolución de la epidemia de enfermedades crónicas no transmisibles en Argentina. Estudio de corte transversal. Rev Argent Salud Pública 2:34–41 Ferrante D, Linetzky B, Konfino J et al (2011) Encuesta Nacional de Factores de Riesgo 2009: evolución de la epidemia de enfermedades crónicas no transmisibles en Argentina. Estudio de corte transversal. Rev Argent Salud Pública 2:34–41
go back to reference Gagliardino JJ, Etchegoyen G et al (2001) A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA). Diabetes Care 24(6):1001–1007PubMedCrossRef Gagliardino JJ, Etchegoyen G et al (2001) A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA). Diabetes Care 24(6):1001–1007PubMedCrossRef
go back to reference Gagliardino JJ, Olivera E, Etchegoyen GS et al (2006) PROPAT: a study to improve the quality and reduce the cost of diabetes care. Diabetes Res Clin Pract 72(3):284–291PubMedCrossRef Gagliardino JJ, Olivera E, Etchegoyen GS et al (2006) PROPAT: a study to improve the quality and reduce the cost of diabetes care. Diabetes Res Clin Pract 72(3):284–291PubMedCrossRef
go back to reference Gagliardino JJ, Aschner P, Baik SH et al (2012) Patients’ education and its impact on care outcomes, resource consumption and working conditions: data from the International Diabetes Management Practices Study (IDMPS). Diabetes Metab 38(2):128–134PubMedCrossRef Gagliardino JJ, Aschner P, Baik SH et al (2012) Patients’ education and its impact on care outcomes, resource consumption and working conditions: data from the International Diabetes Management Practices Study (IDMPS). Diabetes Metab 38(2):128–134PubMedCrossRef
go back to reference Gagliardino JJ, Lapertosa S, Pfirter G et al (2013) Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care (PRODIACOR). Diabet Med 30(9):1102–1111PubMedCrossRef Gagliardino JJ, Lapertosa S, Pfirter G et al (2013) Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care (PRODIACOR). Diabet Med 30(9):1102–1111PubMedCrossRef
go back to reference Hex N, Bartlett C, Wright D, Taylor M, Varley D (2012) Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 29(7):855–862PubMedCrossRef Hex N, Bartlett C, Wright D, Taylor M, Varley D (2012) Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 29(7):855–862PubMedCrossRef
go back to reference Jönsson B, CODE-2 Advisory Board (2002) Revealing the cost of Type II diabetes in Europe. Diabetologia 45(7):S5–S12PubMedCrossRef Jönsson B, CODE-2 Advisory Board (2002) Revealing the cost of Type II diabetes in Europe. Diabetologia 45(7):S5–S12PubMedCrossRef
go back to reference Le C, Lin L, Jun D et al (2013) The economic burden of type 2 diabetes mellitus in rural southwest China. Int J Cardiol 165(2):273–277PubMedCrossRef Le C, Lin L, Jun D et al (2013) The economic burden of type 2 diabetes mellitus in rural southwest China. Int J Cardiol 165(2):273–277PubMedCrossRef
go back to reference Leśniowska J, Schubert A, Wojna M, Skrzekowska-Baran I, Fedyna M (2014) Costs of diabetes and its complications in Poland. Eur J Health Econ 15(6):653–660 Leśniowska J, Schubert A, Wojna M, Skrzekowska-Baran I, Fedyna M (2014) Costs of diabetes and its complications in Poland. Eur J Health Econ 15(6):653–660
go back to reference Rice DP (1967) Estimating the cost of illness. Am J Public Health Nations Health 13(3):424–440CrossRef Rice DP (1967) Estimating the cost of illness. Am J Public Health Nations Health 13(3):424–440CrossRef
go back to reference Trento M, Gamba S, Gentile L et al (2010) Rethink organization to iMprove education and outcomes (ROMEO): a multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes. Diabetes Care 33(4):745–747PubMedCrossRefPubMedCentral Trento M, Gamba S, Gentile L et al (2010) Rethink organization to iMprove education and outcomes (ROMEO): a multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes. Diabetes Care 33(4):745–747PubMedCrossRefPubMedCentral
go back to reference Tunceli K, Bradley CJ, Nerenz D, Williams LK, Pladevall M, Elston Lafata J (2005) The impact of diabetes on employment and work productivity. Diabetes Care 28(11):2662–2667PubMedCrossRef Tunceli K, Bradley CJ, Nerenz D, Williams LK, Pladevall M, Elston Lafata J (2005) The impact of diabetes on employment and work productivity. Diabetes Care 28(11):2662–2667PubMedCrossRef
go back to reference Williams R, Van Gaal L, Lucioni C, CODE-2 Advisory Board (2002) Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 45(7):S13–S17PubMedCrossRef Williams R, Van Gaal L, Lucioni C, CODE-2 Advisory Board (2002) Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 45(7):S13–S17PubMedCrossRef
go back to reference Zhang P, Zhang X, Brown J et al (2010) Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 87(3):293–301PubMedCrossRef Zhang P, Zhang X, Brown J et al (2010) Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 87(3):293–301PubMedCrossRef
go back to reference Zhuo X, Zhang P, Hoerger TJ (2013) Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am J Prev Med 45(3):253–261PubMedCrossRef Zhuo X, Zhang P, Hoerger TJ (2013) Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am J Prev Med 45(3):253–261PubMedCrossRef
Metadata
Title
Direct and indirect costs associated to type 2 diabetes and its complications measured in a social security institution of Argentina
Authors
Jorge F. Elgart
Santiago Asteazarán
Jorge L. De La Fuente
Cecilia Camillucci
Jonathan B. Brown
Juan José Gagliardino
Publication date
01-10-2014
Publisher
Springer Basel
Published in
International Journal of Public Health / Issue 5/2014
Print ISSN: 1661-8556
Electronic ISSN: 1661-8564
DOI
https://doi.org/10.1007/s00038-014-0604-4

Other articles of this Issue 5/2014

International Journal of Public Health 5/2014 Go to the issue